Trial intelligence / Profile preview

Venetoclax + azacitidine + low-dose cytarabine for relapsed or refractory acute myeloid leukemia

ChiCTR2100051018Phase 4Completed

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Oct 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1